Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
WGS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
globenewswire.com
7 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
-0.82
vs -0.20
Q4.23
N/A
-0.59
vs -0.25
Q1.24
N/A
-0.33
vs -2.82
Q2.24
N/A
-0.11
vs -1.65
Q3.24
+105%
0.04
vs -0.82
Q4.24
+219%
0.7
vs -0.59
Q1.25
+185%
0.28
vs -0.33
Q2.25
+555%
0.5
vs -0.11
Q3.25
+933%
0.41
vs 0.04
Q4.25
-12%
0.62
vs 0.7
Sales Growth
YoY
Current
Estimates
Q3.23
-36%
53.3M vs 83.2M
Q4.23
-6%
57.4M vs 61.4M
Q1.24
+45%
62.4M vs 43.1M
Q2.24
+45%
70.5M vs 48.7M
Q3.24
+44%
76.9M vs 53.3M
Q4.24
+67%
95.6M vs 57.4M
Q1.25
+40%
87.1M vs 62.4M
Q2.25
+46%
102.7M vs 70.5M
Q3.25
+36%
104.3M vs 76.9M
Q4.25
+23%
117.2M vs 95.6M
Return on Equity
QoQ
Q1.23
-19%
-0.19
vs -1.22
Q2.23
-16%
-0.16
vs -0.19
Q3.23
-17%
-0.17
vs -0.16
Q4.23
-11%
-0.11
vs -0.17
Q1.24
-10%
-0.10
vs -0.11
Q2.24
-15%
-0.15
vs -0.10
Q3.24
-4%
-0.04
vs -0.15
Q4.24
+2%
0.02
vs -0.04
Q1.25
-3%
-0.03
vs 0.02
Q2.25
+4%
0.04
vs -0.03
Institutionnal Ownership
QoQ
Q1.23
2
2
vs NA
NA
Q2.23
62
62
vs 2
3000%
Q3.23
58
58
vs 62
-6%
Q4.23
50
50
vs 58
-14%
Q1.24
61
61
vs 50
22%
Q2.24
92
92
vs 61
51%
Q3.24
145
145
vs 92
58%
Q4.24
211
211
vs 145
46%
Q1.25
244
244
vs 211
16%
Q2.25
242
242
vs 244
-1%
Quote Panel
Key Metrics
Forecast
377%2026-Revenue
552%2026-EPS
-2197%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
120.00(-3.19%)
Number of analyst
1
Last analyst upgrade/downgrade
Guggenheim
initialisePrevious: Not converted
2025-05-15
Now: Buy
Wells Fargo
initialisePrevious: Not converted
2024-08-27
Now: Equal-Weight
Craig-Hallum
initialisePrevious: Not converted
2024-07-10
Now: Buy
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
NASDAQ
-1.94Â ( -1.54%)
Relative Strenght
94
Volume Buzz
-66%
Earning Acce
No
Dist 52w H.
9%Relative Strength
WGS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How WGS compares to sector?
